CURRENT EUROPEAN FUNDINGS
Gofarm Sp. z o.o. Sp. k. received funding from the Project: Promotion of the “Gofarm Medical Devices” product brand on international markets in 2025-2027, under the European Funds for Modern Economy program, in the amount of PLN 649,794.81. The total project cost is PLN 1,427,766.44.
The activities planned by Gofarm, covering the period from July 1, 2025, to December 31, 2027, are aimed at promoting the Gofarm Medical Devices product brand on international markets in 2025-2027 as part of the “Promotion of the Innovative SME Brand” (FENG 2.25) program, in the pharmaceutical and medical device sectors. The project’s target markets and groups are Europe and Brazil. As part of the project, the company will promote its products as an exhibitor at CPhI 2025 in Germany and the subsequent editions of CPhI 2026 and 2027 in Europe, as well as at Medica 2026. The project includes organizing field missions to The Pharmacy Show 2025 in the UK, the Raucon 2026 and 2027 conferences in Portugal, the Pharma Synergy OTC 2025 conference in Italy and its 2026 edition in a European city, the Pharma Venue 2026 conference in Spain, and the FCE Pharma 2026 trade fair in Brazil. Furthermore, the company is planning a promotional campaign linked to its participation in CPhI Europe 2026.
The project aims to promote the Gofarm Medical Devices brand in European and Brazilian markets by acquiring new business partners and increasing export sales. Effect: As a result of the project’s implementation, it is planned to establish four new trade contacts and increase exports of products covered by the project by 2029.
#FunduszeUE #FunduszeEuropejskie
#EUFunds #EuropeanFunds
“Gofarm Sp. z o.o. Sp. k. has received funding from the Project: Development of the Research and Development Potential of Gofarm Sp. z o.o. Sp. komandytowa for the expansion of its business into drug development and production, under the European Fund for Małopolska 2021-2027 program, in the amount of PLN 1,826,676. The total project cost is PLN 3,265,635.
The Project plans to purchase research and development infrastructure to enable the development of a new area of the company’s business: the development and development of medicinal products.
The activities planned by Gofarm, covering the period from July 1, 2024, to June 30, 2026, are aimed at introducing a business innovation consisting in ensuring the development of medicinal products, with a particular emphasis on concept and formulation, and then introducing them into the company’s portfolio, which will constitute a milestone in the company’s development. The project’s result is the creation of a laboratory with the necessary R&D infrastructure for drug development and formulation. It is planned that drug design and manufacturing will result in the company’s dynamic growth, increasing its regional recognition and competitiveness, while also aligning with the regional smart specialization (RIS) within the Life Sciences domain and the “Innovative Medicines and Other Medicinal Products” field.
Furthermore, the expansion of research and development activities in drug concept development and formulation will result in the employment of specialists with experience in drug development. Therefore, the project will contribute to the increase in the employment of experienced specialists in the fields of biotechnology and/or chemistry, in which Małopolska dominates compared to other Polish regions.
#FunduszeUE #FunduszeEuropejskie
#EUFunds #EuropeanFunds
Project Title
Purchase of R&D services and pro-innovation services for the design and development of a new innovative product by Gofarm Sp. z o.o. Sp. komandytowa.
Project Objective
The objective of the project is to launch a new, innovative product – a reflux gel – addressing the growing social needs resulting from the increasing prevalence of gastroesophageal reflux disease (GERD) in developed countries.
Project Description and Planned Activities
The project involves the procurement of research and development (R&D) and pro-innovation services to implement an innovative, experimental product – a reflux gel.
This product is a medical device with both therapeutic and preventive properties.
As part of the project, the product will undergo toxicity validation (as part of the R&D phase), followed by certification (as part of pro-innovation activities) to enable its market launch. By contracting both services, the company will be able to effectively introduce the product to the market, achieve product innovation, launch a new line of gastroenterological products, and ultimately increase revenue and its share in the medical device market.
Target Group
The target group includes patients struggling with gastroesophageal reflux disease (end users: adults and children over 12 years of age) seeking safe and effective supportive and protective therapies. The target group also includes pharmacy and drugstore chains (business partners) interested in including an innovative medical device in their private label portfolio.
Project Outcomes and Results
The implementation of the project will allow for the launch of a product with a unique formula. The product will be offered under a private label model, which is a novelty in this market segment, enabling business partners to integrate a modern medical device into their own brand portfolios.
- Project Value: PLN 204 303,00
- European Funds Contribution: PLN 141 185, 00
- Project Duration: January 9, 2024 – January 8, 2025
#EUFunds #EuropeanFunds
Any suspicion of non-compliance of the project or the Beneficiary’s activities with the Charter of Fundamental Rights (CFR) or the Convention on the Rights of Persons with Disabilities (CRPD) may be reported to the Managing Authority via email at KPP_KPON@umwm.malopolska.pl or in another format if required by the specific communication needs of the whistleblower. A detailed description of the procedure for reporting non-compliance with CFR/CRPD is available on the FEM program website.
2018/2019 FUNDING
Gofarm Sp. z o.o. Sp. k. received funding from the European Union in the amount of PLN 423,450, which constitutes 75% of eligible expenses for participation in the project:
Development of export activity of Gofarm Sp. z o.o. Sp. k. through promotion on international markets.
Financial assistance is provided under Sub-measure 3.3.3. of the Smart Growth Operational Programme: Support for SMEs in the promotion of product brands – Go to Brand.
The activities planned by Gofarm cover the period from May 2018 to December 2019.
The aim of the project is primarily to develop GOFARM’s export activity by acquiring new business partners, and thus increase export sales. The company will strive to strengthen its position on foreign markets, to establish and develop relationships with business partners and increase sales, which will also directly translate into an increase in the company’s competitiveness and to build a positive image of the company.
Project description:
The GOFARM export development project is being implemented as part of the Biotechnology and Pharmaceuticals Industry Promotion Program, which is an integral part of Sub-measure 3.3.3. Support for SMEs in the promotion of product brands – Go to Brand (POIR).
As part of the project, GOFARM will promote its products at the following events:
– CPhI Worldwide 2018 (Madrid) and 2019 (Frankfurt),
– Middle East Pharma Cold Chain Congress 2019 (Dubai, UAE),
– IPhEB Russia 2019 (St. Petersburg, Russia).
The promotional activities will be additionally complemented by an individual economic mission to the United Arab Emirates and Russia. In addition, the company will benefit from consulting and training services, which will allow it to acquire the knowledge necessary for effective foreign expansion.
Additionally, Gofarm carries out promotional activities: production and distribution of information and promotional materials such as gadgets, printed materials (folders, leaflets, business cards), as well as conducting information and promotional activities in electronic media (positioning of the company’s website) and preparation of the website in Russian.
2020 FUNDING
Gofarm Sp. z o.o. Sp. k. received funding from the European Union in the amount of PLN 198,900, which constitutes 75% of eligible expenses for participation in the project:
Development of export activity of Gofarm Sp. z o.o. Sp. k. through promotion on international markets.
Financial assistance is provided under Sub-measure 3.3.3. of the Smart Growth Operational Program: Support for SMEs in the promotion of product brands – Go to Brand.
The activities planned by Gofarm cover the period from August to December 2020.
The aim of the project is primarily to develop GOFARM’s export activity by acquiring new business partners, and thus increase export sales. The company will strive to strengthen its position on foreign markets, to establish and develop relationships with business partners and increase sales,
which will also directly translate into an increase in the company’s competitiveness and to build a positive image of the company.
Project description:
The GOFARM export activity development project is implemented as part of the Biotechnology and Pharmaceuticals Industry Promotion Program, which is an integral part of Sub-measure 3.3.3. Support for SMEs in the promotion of product brands – Go to Brand (POIR).
As part of the project, GOFARM will promote its products during the following events:
– participation in an outbound mission to the Medipharm 2020 trade fair (Vietnam)
– participation as an exhibitor in the CPhI Worldwide 2020 trade fair (Milan)
– participation in an outbound mission to the CPhI Worldwide 2020 trade fair (Milan)
Additionally, Gofarm carries out promotional activities: production and distribution of information and promotional materials such as gadgets, printed materials (folders, advertising bags), as well as preparation of a film promoting the company’s products and services